The Munich Regional Court ruled there was imminent infringement for Merck & Co.’s Keytruda SC in Germany related to Halozyme’s MDASE patents in Europe, the San Diego company said.
Source link
About The Author
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case